TM
JAZZ icon

Torren Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Torren Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.13K Hold
13
– – ﹤0.01% 452
2026
Q1 		$2.46K Sell
13
-14
-52% -$2.45K ﹤0.01% 494
2025
Q4 		$4.59K Buy
+27
New +$4.14K ﹤0.01% 915

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Torren Management's JAZZ Position: Q2 2026 in Review

Torren Management held its Jazz Pharmaceuticals (JAZZ) position steady in Q2 2026 at 13 shares worth $3.13K. The position accounts for ﹤0.01% of the portfolio, ranked #452.

Torren Management first reported a position in JAZZ in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.59K in Q4 2025. 303 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Torren Management held 13 shares of Jazz Pharmaceuticals worth $3.13K as of Q2 2026.
  • Torren Management left its Jazz Pharmaceuticals share count unchanged in Q2 2026.
  • Jazz Pharmaceuticals made up ﹤0.01% of Torren Management's portfolio in Q2 2026, its #452 holding.
  • Torren Management first reported a position in Jazz Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Torren Management's Jazz Pharmaceuticals position peaked at $4.59K in Q4 2025.
  • 303 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Torren Management's 13F filing for Q2 2026, filed 10 Jul 2026.